Drug Profile
Research programme: autologous stem cell therapies - GWOXI
Latest Information Update: 28 Jun 2019
Price :
$50
*
At a glance
- Originator GWOXI Stem Cell Applied Technology
- Class
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Stroke
Most Recent Events
- 28 Jun 2019 No recent reports of development identified for preclinical development in Stroke in Taiwan